ArticleJournal of immunology (Baltimore, Md. : 1950)2014

CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.

Margaret Gil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.